cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Inari Medical Inc
8 own
6 watching
Current Price
$58.97
$-0.48
(-0.81%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
3,366.23M
52-Week High
52-Week High
86.94
52-Week Low
52-Week Low
52.59
Average Volume
Average Volume
0.69M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
201.9092
iconMarket Capitalization3,366.23M
icon52-Week High86.94
icon52-Week Low52.59
iconAverage Volume0.69M
iconDividend Yield--
iconP/E Ratio201.9092
What does the Inari Medical Inc do?
We are a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Our initial product offering consists of two minimally-invasive, novel catheter-based mechanical thrombectomy devices. We purpose-built our products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE – deep vein thrombosis and pulmonary embolism. Our ClotTriever product is FDA-cleared for the removal of clot from peripheral blood vessels and is used to treat patients suffering from deep vein thrombosis, or DVT. We were formed under the laws of the state of Delaware in July 2011 under the name Inceptus Newco1 Inc. and changed our name to Inari Medical, Inc. in September 2013. Our principal executive offices are located at 9 Parker, Suite 100, Irvine, CA 92618 and our telephone number is (877) 923-4747. Our website address is www.inarimedical.com.
Read More
How much money does Inari Medical Inc make?
News & Events about Inari Medical Inc.
Zolmax
2 months ago
Inari Medical (NASDAQ:NARI Get Rating) and iCAD (NASDAQ:ICAD Get Rating) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, risk, valuation and ...
Ticker Report
2 months ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) CEO Andrew Hykes sold 9,000 shares of Inari Medical stock in a transaction that occurred on Monday, March 20th. The shares were sold at an average price of $64.29, for a total transaction of $578,610.00. Following the completion of the transaction...
Globe Newswire
2 months ago
IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (Inari) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary ...
Ticker Report
2 months ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) has been given an average rating of Moderate Buy by the ten analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a ...
Ticker Report
4 months ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) CEO Andrew Hykes sold 9,000 shares of the firms stock in a transaction that occurred on Friday, January 20th. The stock was sold at an average price of $61.90, for a total transaction of $557,100.00. Following the transaction, the chief ...
Frequently Asked Questions
Frequently Asked Questions
What is Inari Medical Inc share price today?
plus_minus_icon
Can Indians buy Inari Medical Inc shares?
plus_minus_icon
How can I buy Inari Medical Inc shares from India?
plus_minus_icon
Can Fractional shares of Inari Medical Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Inari Medical Inc stocks?
plus_minus_icon
What is today’s traded volume of Inari Medical Inc?
plus_minus_icon
What is today’s market capitalisation of Inari Medical Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Inari Medical Inc?
plus_minus_icon
What percentage is Inari Medical Inc down from its 52-Week High?
plus_minus_icon
What percentage is Inari Medical Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$58.97
$-0.48
(-0.81%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Related Stocks
TRANSMEDICS GROUP INC
TRANSMEDICS GROUP INC
$70.68
$-0.65 (-0.91 %)
Olink Holding AB
Olink Holding AB
$19.94
$0.20 (1.01 %)
ImmunityBio Inc.
ImmunityBio Inc.
$2.54
$0.16 (6.72 %)
Outset medical Inc
Outset medical Inc
$21.41
$1.18 (5.83 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.
Related Stocks
TRANSMEDICS GROUP INC
TRANSMEDICS GROUP INC
$70.68
$-0.65 (-0.91 %)
Olink Holding AB
Olink Holding AB
$19.94
$0.20 (1.01 %)
ImmunityBio Inc.
ImmunityBio Inc.
$2.54
$0.16 (6.72 %)
Outset medical Inc
Outset medical Inc
$21.41
$1.18 (5.83 %)
Sign up and dive into a whole new world of investing.
Join over 370,000 who have signed up and are using Stockal successfully already.

              Borderless Investing Inc., (“Borderless Investing”), the owner of the Stockal Platform, is not a broker-dealer nor an investment advisor and through its affiliate stockbroker Stockal Securities Pvt. Ltd., (SEBI INZ000301236), acting as the introducing entity has entered into a clearing agreement with DriveWealth LLC., to offer U.S. equities on the Stockal Platform. The Stockal Platform enables investments in a diverse set of global assets from a single account from anywhere in the world. As such, Borderless Investing makes no warranties or representations, express or implied, on products and services offered through its website/platform. It accepts no liability for any damages or losses, however, caused in connection with the use of related services.

              All investments involve risk and returns will fluctuate, are subject to market volatility and may cause losses. The material on this website/platform is provided solely for informational and educational purposes and shall not in any manner be considered a recommendation or endorsement of any strategy or investment, nor an offer to sell or a solicitation of an offer to buy securities, products or services nor advice. Borderless Investing makes no guarantee as to the currency, accuracy, or quality of information published and/or archived on this website/platform, nor will Borderless Investing accept any responsibility for other organizations, businesses, and private persons that provide information on this website/platform. All information on this website/platform regarding products and services provided by Borderless Investing is subject to change without notice. Reasonable efforts are taken to ensure the accuracy and integrity of all information provided here, but Borderless Investing is not responsible for misprints, out of date information, or errors. Any investment decision and/or strategy that investors make or employ, whether or not such decision or strategy derives from or relies upon material accessed or provided through this website/platform, is undertaken at the investor’s sole discretion and risk. Before making any investment decisions, investors should consult additional sources of information and/or their legal or tax advisor. PLEASE READ THIS FULL DISCLOSURE CAREFULLY BEFORE USING THIS SERVICE. BY USING THE SERVICE OR CLICKING AGREE YOU ARE AGREEING TO BE BOUND BY THESE DISCLOSURES AND ALL TERMS AND CONDITIONS ON THIS WEBSITE/PLATFORM.

              *DriveWealth LLC., a member of the Securities Investor Protection Corporation (SIPC), will serve as the custodian for your securities account. In the event that DriveWealth LLC., fails and is placed in liquidation under the Securities Investor Protection Act, securities in your brokerage account may be protected up to $500,000. For details, please see www.sipc.org.

              All brands and logos used on this website are the property of their respective owners.

              Get Started with as little as $1.00